ArticleScientific reports2025

High-selective HDAC6 inhibitor alleviates bone marrow fibrosis through inhibiting collagen formation and extracellular matrix deposition.

Chiao-Hsu Ke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.